Previously, FRET has been used in XIAP signaling to quantify the distance between the BIR2 and BIR3 domains in determining the additional hydrophobic binding surface area versus the BIR3 domain alone for the enhancement of a SMAC peptide mimetic that enhances caspase-driven apoptosis for cancer therapeutics [42]. Here, XIAP is linked to cancer.